Home›Research›Compare›Eloralintide vs Liraglutide
Peptide ComparisonEloralintide vs Liraglutide
Both are Metabolic peptides.
Eloralintide
LY3841136
Half-life: Not published
3 providers listed
Liraglutide
Victoza
Half-life: 13 hours
53 providers listed
Liraglutide is FDA-approved, while Eloralintide is investigational — the clearest structural difference between them.
Eloralintide
Half-life
Not published
Liraglutide
Half-life
13 hours
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Liraglutide |
| Further along in FDA review | Liraglutide |
| More provider options (3 vs 53) | Liraglutide |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Eloralintide
Liraglutide
Eloralintide
Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A N…
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of con…
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentr…
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to cli…
Liraglutide
Comparative Effects of Individual Glucagon-Like Peptide-1 Receptor Agonist-Based Medications on Direct Measur…
Semaglutide vs liraglutide for weight loss in adults with overweight or obesity
A randomized, controlled trial of 3.0 mg of liraglutide in weight management
Effects of the GLP-1 receptor agonist liraglutide on bupivacaine-induced sciatic nerve block in a rat model.
+4 more
About Eloralintide
Selective long-acting amylin receptor agonist; preferentially activates AMY1R over the calcitonin receptor to prolong satiety and slow gastric emptying
About Liraglutide
GLP-1 receptor agonist; slows gastric emptying, increases satiety, reduces glucagon secretion
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Eloralintide
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
No amylin-specific monitoring protocol is established for eloralintide, which remains investigational and is available only through clinical trials. Trial programmes track a baseline metabolic panel covering glycaemic markers, renal and hepatic function, and lipase. Calcitonin and TSH are carried over from incretin-class convention rather than from any eloralintide-specific signal, as the compound is designed for reduced calcitonin receptor activity.
Liraglutide
Risk of thyroid C-cell tumors (dose- and duration-dependent in rodents; human relevance undetermined).
Source: FDA label
Under clinical review
Being verified by our medical team before we display monitoring guidance for this peptide.
Eloralintide
Liraglutide
Not enough vendor pricing yet.
Where to source these peptides
Eloralintide
3 listed
Browse directory →
Providers offeringLiraglutide
53 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Metabolic Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated October 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Eloralintide vs Liraglutide — Per-mg Price Comparison. Retrieved October 26, 2026, from https://peptidebase.io/peptides/compare/eloralintide/liraglutide